Since rare cases of pancytopenia, and very rare cases of aplastic anemia, some of which with fatal outcome, have been reported in patients treated with anti-TNF, caution should be used in patients receiving treatment with anti-TNF who have a history of blood dyscrasias (111). This evidence concerns the gene TNF and aplastic anemia.